%0 Case Reports
%T Rapid resolution of erythrodermic atopic dermatitis with upadacitinib: A case report.
%A Saad M
%A Guirguis M
%A Hamm C
%A Bose R
%J SAGE Open Med Case Rep
%V 12
%N 0
%D 2024
%M 38881978
暂无%R 10.1177/2050313X241260497
%X Atopic dermatitis is a chronic inflammatory skin disease that may progress to erythroderma in severe cases. Biologic agents such as dupilumab have recently become the mainstay of systemic treatment for moderate-to-severe cases, yet many patients remain refractory to therapy. Here, we present a case of erythrodermic atopic dermatitis, resistant to prednisone and dupilumab, with remarkably rapid achievement of remission following treatment with upadacitinib, an oral selective Janus kinase 1 inhibitor.